Metastatic breast cancer: Endocrine therapy landscape reshaped
Endocrine therapy (ET) of hormone receptor (HR)-positive and human epidermal growth factor receptor 2-(HER2)-negative metastatic breast cancer (MBC) historically focused on estrogen deprivation and antagonism. The identification of several intracellular pathways promoting resistance to antiestrogen...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2017
|
| Subjects: | |
| Online Access: | https://doaj.org/article/3269b6d99960484c8d2f4b76e075e6f0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!